was unwarranted and contrary to French administrative law, and we  are challenging the decision. Through these efforts, we are seeking to  minimize the interruption in existing and future bifenthrin sales in  the European market. We intend to defend vigorously all our products in the U.S., EU and  other countries’ regulatory processes where FMC’s pesticide products  will be reviewed in the ordinary course of regulatory programs during  2011 as part of the ongoing cycle of re-registration in countries around  the world. The Brazilian health surveillance agency has informed us  that they intend to review carbofuran along with 13 other major  pesticides, but has yet to issue any required formal announcement  that identifies their specific concerns or preliminary position on re- registration. FMC is cooperating and defending our product in this  process. Under the Brazilian regulatory process, any recommendation  would require public notice and comment as well as concurrence from  the Brazilian environmental and agricultural ministries before any  regulatory change is effective. Thus, we do not expect a potential sales  impact in Brazil in 2011. Part II  iteM 7 Management’s Discussion and analysis of Financial Condition and results of operations Specialty Chemicals Revenue in Specialty Chemicals was $824.5 million, an increase of  approximately nine percent versus the prior-year period. The increase  was driven primarily by a robust demand recovery in lithium primaries  and strong commercial performance in BioPolymer. BioPolymer revenues of $611.5 million increased six percent from the  prior-year period. This increase was primarily due to higher volumes  which increased revenue by five percent. BioPolymer experienced  broad-based volume gains across both food and pharmaceutical markets.  Additionally, improved pricing and mix increased revenue, driven  primarily by higher pricing in food ingredients. increased revenue by 29 percent while the lower pricing impacted  revenues downward by seven percent. The improving economic  conditions in lithium are driven primarily by growth in battery and  metals markets in Asia. Segment operating profit of $185.0 million increased 16 percent versus  the year ago period, as volume gains in lithium primaries, favorable  commercial performance in BioPolymer and the benefits of productivity  initiatives were partially offset by higher raw material costs. In 2011, we expect full-year revenue growth in the mid-single digits,  driven by favorable commercial performance in BioPolymer and higher  selling prices and favorable mix in lithium. Full-year segment operating  profit growth is expected in the low teens reflecting higher sales across  all businesses and continued productivity improvements. Lithium revenues of $213.0 million increased 22 percent from the  prior-year period primarily due to higher volumes driven by improving  economic conditions slightly offset by lower pricing. Higher volumes  Revenue in Industrial Chemicals was $1,054.8 million, an increase of  approximately three percent versus the prior-year period. An increase in  volumes across the segment increased revenues by eight percent which  was offset by a seven percent decline in pricing. Soda ash revenues were  up due to increased volumes, particularly in the export market, partially  offset by lower prices. The segment experienced volume increases in  peroxygens and phosphates offset by reduced selling prices for these  products. The higher volumes in the segment also resulted in increased  freight billings which increased revenue by three percent. The segment  was also negatively impacted by $12 million or one percent decrease  due to lower electricity sales due to the divestiture of a Spanish co- generation facility in the third quarter of 2009. In Spain, we operate  electricity co-generation facilities and sell excess electricity into the  Spanish electrical grid. Segment operating profit of $122.9 million increased approximately  37 percent versus the year ago period, driven by the strong demand  recovery and lower raw material, particularly phosphate rock, and energy  costs which more than offset lower selling prices across the segment. Recent events in Venezuela, such as hyperinflation, devaluation of  currency, government price controls, parallel exchange rates, and political  issues have created significant risks and uncertainties for the Venezuelan  operations of U.S.-based companies. Our Spanish subsidiary, FMC  Foret, holds a noncontrolling interest in a Venezuelan joint-venture  named Tripoliven. The value of this investment on our consolidated  balance sheet at December 31, 2010 is approximately $9 million. While  the receipts of collecting dividends from this entity have slowed, we  continued to receive dividends from the entity during 2010. We do  not believe there is any impairment of the entity at December 31, 2010  and, in light of the facts and circumstances noted above, will continue  to monitor this situation. The risks associated with this entity would  have an immaterial impact on our liquidity or consolidated financial  position but could result in an impact to our results of operations in  any one period in the form of an impairment charge. In 2011, we expect full-year revenue to be approximately 5 percent  lower as growth in soda ash and peroxygens will be offset by the absence  of revenue from the exited phosphate business, which occurred at the  end of 2010. Full-year operating profit growth is expected in the mid- twenties driven by higher selling prices and volume growth augmented  by the benefit of cost reduction initiatives. 22 FMC Corporation    2010 Form 10K (in Millions) Year Ended December 31, Increase/(Decrease) 2010 2009 $ % Revenue $824.5 $753.1 $71.4 9% Operating Profit 185.0 159.6 25.4 16 (in Millions) Year Ended December 31, Increase/(Decrease) 2010 2009 $ % Revenue $1,054.8 $1,026.7 28.1 3% Operating Profit 122.9 89.7 33.2 37 Industrial Chemicals